|Table of Contents|

Trend of mortality and disease burden of liver cancer from 2012 to 2020 in Chongqing

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 06
Page:
1136-1140
Research Field:
Publishing date:

Info

Title:
Trend of mortality and disease burden of liver cancer from 2012 to 2020 in Chongqing
Author(s):
DING Xianbin1; HE Daxue2; LIAN Xuemei2; MAO Deqiang1; JIAO Yan1; LYU Xiaoyan1
1.Institute of Non-communicable Disease Control and Prevention,Chongqing Center for Disease Control and Prevention,Chongqing 400042,China；2.Department of Nutrition and Food Hygiene,School of Public Health and Management,Chongqing Medical University,Chongqing 400016,China.
Keywords:
liver cancer; mortality; disease burden
PACS:
R73-31
DOI:
10.3969/j.issn.1672-4992.2023.06.030
Abstract:
Objective：To study the trend of mortality and disease burden of liver cancer from 2012 to 2020 in Chongqing.Methods:Case data of liver cancer deaths (ICD-10:C22) were obtained from the database of mortality surveillance report in Chongqing.SPSS 26.0 was used to statistically analyze the mortality rate,standardized mortality rate by Chinese standard population,years of life lost (YLL) and average years of life lost (AYLL).The χ2 test was used to analyze the difference between male and female，urban area and rural area.The annual percentage change （APC） was used to analyze the trend by t test.Results:The mortality rate and standardized mortality rate of liver cancer in Chongqing were 29.87/100 000 and 20.27/100 000 in 2012 and 31.21/100 000 and 18.16/100 000 in 2020,respectively and their APC were 0.39% and -0.83%,respectively,with no statistically significant trend (P＞0.05).The mortality rate of liver cancer in males was higher than that of females in all calendar years from 2012 to 2020,and the difference was statistically significant (P＜0.01).The mortality rate of liver cancer in rural areas was higher than that of urban areas in all calendar years from 2012 to 2020,and the difference was statistically significant (P＜0.01).The YLL rate due to liver cancer in Chongqing was 8.72 per 1 000 in 2012 and 8.02 per 1 000 in 2020,with a YLL rate APC of -1.28%,with no statistically significant trend (P＞0.05) and AYLL declining at an average annual rate of 1.66% (P＜0.05).Male AYLL was higher than female,declining at an annual rate of 1.55% (P＜0.05) and 1.96% (P＜0.05) respectively,and urban AYLL was lower than rural AYLL,with urban and rural AYLL overall declining at an annual rate of 1.59% (P＜0.05) and 1.72% (P＜0.05).Conclusion:The mortality of liver cancer and the disease burden caused by early death in Chongqing are higher.Males and rural residents are the key groups of liver cancer.

References:

［1］ ARNOLD M,ABNET CC,NEALE RE,et al.Global burden of 5 major types of gastrointestinal cancer［J］.Gastroenterology,2020,159(1):37.
[2] SUNG H,FERLAY J,SIEGEL RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］.CA Cancer J Clin,2021,71(3):209-249.
[3] WONG MCS,JIANG JY,GOGGINS WB,et al.International incidence and mortality trends of liver cancer:a global profile［J］.Scientific Reports,2017,7:45846.
[4] LLOVET JM,KELLEY RK,VILLANUEVA A,et al.Hepatocellular carcinoma［J］.Nat Rev Dis Primers,2021,7(1):6.
[5] 丁贤彬,焦艳,毛德强,等.2012-2018年重庆市阿尔茨海默病死亡率及疾病负担变化趋势 ［J］.中国慢性病预防与控制,2020,28(09):665-668. DING XB,JIAO Y,MAO DQ,et al.Trend of mortality and disease burden of Alzheimer disease from 2012 to 2018 in Chongqing［J］.Chinese Prevention and Control of Chronic Non-Communicable Disease,2020,28(09):665-668.
[6] 高力群.内蒙古肝癌疾病负担及临床特征回顾性分析［D］.呼和浩特：内蒙古医科大学,2019. GAO LQ.Retrospective analysis on disease burden and clinical characteristics of liver cancer in Inner Mongolia［D］.Hohhot：Inner Mongolia Medical University,2019.
[7] 徐华,李小攀,陈易晨,等.2010-2016年上海市某社区恶性肿瘤相关死亡及减寿情况分析［J］.中国全科医学,2019,22(33):4137-4141. XU H,LI XP,CHEN YC,et al.Mortality and potential years of life lost associated with cancer among residents from a community in Shanghai，2010-2016［J］.Chinese General Practice,2019,22(33):4137-4141.
[8] 丁贤彬,唐文革,吕晓燕,等.2010-2017年重庆市肺癌疾病负担变化趋势研究［J］.中华肿瘤防治杂志,2020,27(05):331-336. DING XB,TANG WG,LYU XY,et al.Study on trend change of disease burden of lung cancer in Chongqing from 2012 to 2020［J］.Chinese Cancer Prev Treat,2020,27(05):331-336.
[9] 丁贤彬,吕晓燕,毛德强,等.2010～2017年重庆市宫颈癌疾病负担变化趋势分析［J］.中国肿瘤,2019,28(09):657-662. DING XB,LYU XY,MAO DQ,et al.Trend analysis of disease burden of cervical cancer from 2010 to 2017 in Chongqing［J］.China Cancer,2019,28(09):657-662.
[10] 周家琛,郑荣寿,王少明,等.2020年中国和世界部分国家主要消化道肿瘤负担比较［J］.肿瘤综合治疗电子杂志,2021,7(02):26-32. ZHOU JC,ZHENG RS,WANG SM,et al.Comparation between the burden of major digestive tract cancers in China and 19 countries in the world in 2020［J］.Multidisciplinary Cancer Management(Electronic Version),2021,7(02):26-32.
[11] 孙可欣,郑荣寿,张思维,等.2015年中国分地区恶性肿瘤发病和死亡分析［J］.中国肿瘤,2019,28(01):1-11. SUN KX,ZHENG RS,ZHANG SW,et al.Report of cancer incidence and mortality in different areas of China，2015［J］.China Cancer,2019,28(01):1-11.
[12] 曹梦迪,王红,石菊芳,等.中国人群肝癌疾病负担：多数据源证据更新整合分析［J］.中华流行病学杂志,2020,41(11):1848-1858. CAO MD,WANG H,SHI JF,et al.Disease burden of liver cancer in China:an updated and integrated analysis on multi-data source evidence［J］.Chinese Epidemiol,2020,41(11):1848-1858.
[13] 丁贤彬,吕晓燕,焦艳,等.2010-2018年重庆市恶性肿瘤发病死亡趋势分析［J］.现代肿瘤医学,2020,28(24):4351-4358. DING XB,LYU XY,JIAO Y,et al.Trend of incidence and mortality of cancer in Chongqing，2010－2018［J］.Modern Oncology,2020,28(24):4351-4358.
[14] 王鹏举.1990-2019年我国肝癌发病与死亡趋势及预测研究［D］.兰州：兰州大学,2021. WANG PJ.Study on the trend and prediction of the incidence and mortality of liver cancer in China from 1990 to 2019［D］.Lanzhou：Lanzhou University,2021.
[15] CHEN W,ZHENG R,ZUO T,et al.National cancer incidence and mortality in China,2012［J］.Chin J Cancer Res,2016,28(1):56.
[16] 赵沛,蒋栋铭,鲜林峰,等.2004-2018年中国大陆地区原发性肝癌死亡率分析［J］.上海预防医学,2021,33(10):881-886. ZHAO P,JIANG DM,XIAN LF,et al.Mortality analysis of primary liver cancer in the mainland of China from 2004 to 2018［J］.Shanghai Prev Med,2021,33(10):881-886.
[17] CHEN W,XIA C,ZHENG R,et al.Disparities by province,age,and sex in site-specific cancer burden attributable to 23 potentially modifiable risk factors in China:a comparative risk assessment［J］.Lancet Glob Health,2019,7(2):e257-e269.
[18] 徐刚,杨静,陈英,等.2010年与2015年江西省老年人群恶性肿瘤疾病负担研究［J］.实用预防医学,2018,25(11):1307-1312. XU G,YANG J,CHEN Y,et al.Disease burden of malignant tumors among senior citizens in Jiangxi Province in 2010 and 2015［J］.Practical Prev Med,2018,25(11):1307-1312.
[19] 车锡嘏,尹厚源,兰亚佳,等.农村社区原发性肝癌危险因素的多因素分析［J］.现代预防医学,1996,23(02):28-30. CHE XG,YIN HY,LAN YJ,et al.Multivariate analysis of the risk factors of HCC a case-control study in rural community ［J］.Modern Prev Med,1996,23(02):28-30.
[20] 池家煌,林艺兰,伍啸青,等.2010-2014年厦门市居民肝癌疾病负担分析［J］.实用预防医学,2017,24(01):9-11. CHI JH,LIN YL,WU XQ,et al.Disease burden of liver cancer in residents in Xiamen City,2010-2014［J］.Practical Prev Med,2017,24(01):9-11.
[21] 闫贻忠,王文瑾,李述刚,等.2016-2017年石河子市恶性肿瘤死亡及疾病负担情况分析［J］.中国全科医学,2019,22(15):1823-1829. YAN YZ,WANG WJ,LI SG,et al.Mortality and disease burden of cancer in Shihezi from 2016 to 2017［J］.Chinese General Practice,2019,22(15):1823-1829.
[22] 杨静.2010年与2015年江西省居民主要恶性肿瘤疾病负担的变化研究［D］.南昌：江西中医药大学,2020. YANG J.Study on the change in the burden of major malignant tumors among residents in Jiangxi Province,2010 and 2015［D］.Nanchang：Jiangxi University of Traditional Chinese Medicine,2020.
[23] 陈亦晨,曲晓滨,孙良红,等.2002-2019年上海市浦东新区居民肝癌死亡特征及减寿率分析［J］.中国全科医学,2021,24(12):1517-1522. CHEN YC,QU XB,SUN LH,et al.Liver carcinoma-related mortality and potential years of life lost among residents in Pudong New Area of Shanghai between 2002 and 2019［J］.Chinese General Practice,2021,24(12):1517-1522.
[24] 周金意,罗鹏飞,俞浩,等.2013年江苏省居民恶性肿瘤死亡和潜在减寿分析［J］.南京医科大学学报(自然科学版),2016,36(12):1561-1566. ZHOU JY,LUO PF,YU H,et al.Analysis of the mortality and PYLL related to malignancies in Jiangsu，2013［J］.Nanjing Medical University(Natural Sciences),2016,36(12):1561-1566.

Memo

Memo:
国家重点研发计划（编号：2017YFC0907303）
Last Update: 1900-01-01